"AIDS Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines containing antigens are recombinantly produced.
| Descriptor ID |
D016915
|
| MeSH Number(s) |
D20.215.894.899.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "AIDS Vaccines".
Below are MeSH descriptors whose meaning is more specific than "AIDS Vaccines".
This graph shows the total number of publications written about "AIDS Vaccines" by people in this website by year, and whether "AIDS Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 2 | 1 | 3 |
| 2007 | 2 | 0 | 2 |
| 2008 | 3 | 0 | 3 |
| 2009 | 3 | 0 | 3 |
| 2010 | 3 | 0 | 3 |
| 2011 | 0 | 1 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 0 | 3 | 3 |
| 2014 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "AIDS Vaccines" by people in Profiles.
-
Morales CG, Jimenez NR, Herbst-Kralovetz MM, Lee NR. Novel Vaccine Strategies and Factors to Consider in Addressing Health Disparities of HPV Infection and Cervical Cancer Development among Native American Women. Med Sci (Basel). 2022 09 13; 10(3).
-
Santos S, Ram?rez M, Miranda E, Reyes N, Mart?nez O, Acosta-Santiago M, Rivera JM, Otero M. Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases. J Immunol Res. 2019; 2019:3409371.
-
Hulgan T, Dash C, Haas DW, Phillips EJ. Precision HIV care: responding to old questions and meeting new challenges. Pharmacogenomics. 2018 11; 19(17):1299-1302.
-
Carrion AJ, Miles JD, Mosley JF, Smith LL, Prather AS, Gurley MM, Phan LD, Everton EC. Prevention Strategies Against HIV Transmission: A Proactive Approach. J Pharm Pract. 2018 Feb; 31(1):82-90.
-
Lee SJ, Newman PA, Duan N, Cunningham WE. Development of an HIV vaccine attitudes scale to predict HIV vaccine acceptability among vulnerable populations: L.A. VOICES. Vaccine. 2014 Sep 03; 32(39):5013-8.
-
Newman PA, Lee SJ, Rudy ET, Diamant A, Duan N, Nakazono T, Nakazano T, Cunningham WE. Endorsement of compulsory HIV vaccination policy among populations at high risk of HIV exposure (LA VOICES). Prev Sci. 2014 Jun; 15(3):428-35.
-
Deschamps MM, Zorrilla CD, Morgan CA, Donastorg Y, Metch B, Madenwald T, Joseph P, Severe K, Garced S, Perez M, Escamilia G, Swann E, Pape JW. Recruitment of Caribbean female commercial sex workers at high risk of HIV infection. Rev Panam Salud Publica. 2013 Aug; 34(2):92-8.
-
Khayat R, Lee JH, Julien JP, Cupo A, Klasse PJ, Sanders RW, Moore JP, Wilson IA, Ward AB. Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers. J Virol. 2013 Sep; 87(17):9865-72.
-
Date AA, Destache CJ. A review of nanotechnological approaches for the prophylaxis of HIV/AIDS. Biomaterials. 2013 Aug; 34(26):6202-28.
-
Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Gilbert P, Corey L, Robertson MN. Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study). J Infect Dis. 2012 Jul 15; 206(2):258-66.